NPPB and hydrops fetalis: Collectively, these findings support the use of 6MWT for risk stratification in HF and suggest that combining SFI with established risk markers, including NT-proBNP that is recognized as the strongest prognostic marker, can significantly improve the accuracy of risk prediction and provide a meaningful improvement in the identification of the patients at risk of death.